Status epilepticus differentially alters AMPA and kainate receptor subunit expression in mature and immature dentate granule neurons
- PMID: 16819974
- DOI: 10.1111/j.1460-9568.2006.04839.x
Status epilepticus differentially alters AMPA and kainate receptor subunit expression in mature and immature dentate granule neurons
Abstract
There is an increase in the birth of dentate granule neurons after status epilepticus (SE) and there are concurrent alterations in neurotransmitter receptor expression that may contribute to the development of spontaneous seizures. To determine whether newborn and/or mature dentate granule neurons have altered neurotransmitter receptor expression after SE, we dissected individual immature, PSA-NCAM-expressing, or mature, NeuN-expressing, dentate granule neurons 2 weeks after lithium-pilocarpine-induced SE in postnatal day 20 rats. Amplified single-cell RNA was used to probe reverse Northern blots containing alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) and kainate neurotransmitter receptor subunits. Two weeks after lithium-pilocarpine-induced SE there were increases in AMPA GluR2 and kainate KA2 subunit mRNA and decreases in AMPA GluR3 and kainate GluR6 receptor subunit mRNA levels in mature dentate granule neurons. In contrast, only the kainate GluR6 subunit expression was reduced in immature dentate granule neurons after SE. Alterations in transcription of excitatory amino acid receptor subunits after SE occur primarily in the mature population of dentate granule neurons. Our findings suggest that neurotransmitter receptor gene expression is altered differently in immature and mature dentate granule neurons following SE, and may result in differential contributions of these two groups of dentate granule neurons to the subsequent development of epilepsy.
Similar articles
-
Increased GABA(A)-receptor alpha1-subunit expression in hippocampal dentate gyrus after early-life status epilepticus.Epilepsia. 2006 Oct;47(10):1665-73. doi: 10.1111/j.1528-1167.2006.00640.x. Epilepsia. 2006. PMID: 17054689
-
Levetiracetam suppresses development of spontaneous EEG seizures and aberrant neurogenesis following kainate-induced status epilepticus.Brain Res. 2010 Sep 17;1352:187-99. doi: 10.1016/j.brainres.2010.06.061. Epub 2010 Jun 30. Brain Res. 2010. PMID: 20599805
-
Spontaneous recurrent seizure following status epilepticus enhances dentate gyrus neurogenesis.Brain Dev. 2004 Sep;26(6):394-7. doi: 10.1016/j.braindev.2003.12.006. Brain Dev. 2004. PMID: 15275703
-
Structural changes for adult-born dentate granule cells after status epilepticus.Epilepsia. 2008 Jun;49 Suppl 5:13-8. doi: 10.1111/j.1528-1167.2008.01633.x. Epilepsia. 2008. PMID: 18522596 Review.
-
Chronic epileptogenic cellular alterations in the limbic system after status epilepticus.Epilepsia. 1999;40 Suppl 1:S23-33; discussion S40-1. doi: 10.1111/j.1528-1157.1999.tb00875.x. Epilepsia. 1999. PMID: 10421558 Review.
Cited by
-
SAD-B modulates epileptic seizure by regulating AMPA receptors in patients with temporal lobe epilepsy and in the PTZ-induced epileptic model.Braz J Med Biol Res. 2020 Apr 6;53(4):e9175. doi: 10.1590/1414-431X20199175. eCollection 2020. Braz J Med Biol Res. 2020. PMID: 32267308 Free PMC article.
-
Alterations in Properties of Glutamatergic Transmission in the Temporal Cortex and Hippocampus Following Pilocarpine-Induced Acute Seizures in Wistar Rats.Front Cell Neurosci. 2017 Aug 31;11:264. doi: 10.3389/fncel.2017.00264. eCollection 2017. Front Cell Neurosci. 2017. PMID: 28912687 Free PMC article.
-
Concepts of connectivity and human epileptic activity.Front Syst Neurosci. 2011 Mar 22;5:12. doi: 10.3389/fnsys.2011.00012. eCollection 2011. Front Syst Neurosci. 2011. PMID: 21472027 Free PMC article.
-
Relevance of basic research to clinical data: good answers, wrong questions!Epilepsy Curr. 2008 Jan-Feb;8(1):19-22. doi: 10.1111/j.1535-7511.2007.00222.x. Epilepsy Curr. 2008. PMID: 18265884 Free PMC article.
-
Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.J Neural Transm (Vienna). 2014 Aug;121(8):1029-75. doi: 10.1007/s00702-014-1193-3. Epub 2014 Aug 1. J Neural Transm (Vienna). 2014. PMID: 25081016 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous